U.S. Biotech Stock News

If you have ever wondered whether Domino's Pizza at around $431 a share is still a buy, or if the best slices of upside have already been eaten, this breakdown is for you. The stock has been a bit choppy recently, slipping about 0.1% over the last week but still up 5.9% over the past month, while longer term returns of 2.9% over 1 year and 27.6% over 3 years hint at a business that has rewarded patient holders despite a slightly softer 0.8% year to date move. Investors have been reacting to...

If you are wondering whether Reddit's stock price already reflects the hype or if there is still real value left on the table, you are not alone. That is exactly what we are about to unpack. After a strong run, with the share price up 3.7% over the last week, 27.1% over the past month, and 40.6% year to date, the market is clearly starting to price in higher growth expectations and possibly a shifting view of risk. Recent moves have come alongside ongoing headlines about Reddit's expanding...

If you are wondering whether MGIC Investment is still a smart buy after such a strong run, or if the easy money has already been made, you are in the right place. The stock has climbed 2.1% over the last week, 4.7% over the past month, and is now up 25.2% year to date and 27.9% over the last year, with a striking 145.8% gain over three years and 170.5% over five. Behind these moves, investors have largely been reacting to a steadier backdrop for US housing and credit quality, along with more...

Wondering if Coca-Cola FEMSA. de is still worth buying after its strong run, or if the fizz has already gone from the stock price? This article is going to unpack what the market might be missing in its valuation. The share price has climbed to around $94.96, delivering roughly 1.8% over the last week, 7.4% over the past month, and 22.1% year to date, alongside 24.1% over 1 year, 51.0% over 3 years, and 155.7% over 5 years. This naturally raises questions about how much upside is...

Wondering if New York Times stock is still worth buying after its big run, or if the easy money has already been made? Let us break down what the market is really pricing in here. The shares have climbed 4.1% over the last week, 10.4% over the past month, and are up a striking 35.3% year to date, adding to a 35.6% gain over the last year and 121.6% over three years. Some of that momentum has been fueled by ongoing enthusiasm around its growing digital subscription base and the strength of...

In recent days, Mastercard disclosed a series of partnerships and product launches, including Loan on Card with LoanPro, expanded wallet capabilities with TerraPay, and enhanced ecommerce acceptance with WooCommerce, alongside a 14% quarterly dividend increase to US$0.87 per share and authorization for up to US$14.00 billion in share repurchases. Together, these moves signal Mastercard’s push to deepen its role in digital lending and wallets while returning more cash to shareholders through...

Earlier this month, Mizuho Securities analyst Yaron Kinar downgraded Everest Group to a hold rating, signaling a more cautious stance on the insurer. The downgrade comes from an analyst with a very strong one-year track record, which may carry extra weight in shaping investor expectations. Next, we'll assess how this high-conviction downgrade could influence Everest Group's investment narrative and risk-reward profile. Explore 28 top quantum computing companies leading the revolution in...

Corporación América Airports (NYSE:CAAP) just posted another month of steady traffic growth, with November passenger numbers up about 9% year on year and Argentina leading gains thanks to new routes and added frequencies. See our latest analysis for Corporación América Airports. The market seems to be catching on to that steady operational momentum, with a 30 day share price return of 13.71% and a powerful three year total shareholder return above 200% underscoring how sentiment has shifted...

If you are wondering whether Nasdaq is still attractive after such a strong run, or if the upside has already been priced in, this article will walk you through what the numbers say about its value. Nasdaq's share price has climbed to around $95.36, delivering roughly 1.9% over the last week, 10.9% over the last month, and 23.2% year to date, with 24.2% over 1 year, 62.4% over 3 years, and 138.1% over 5 years. Behind those gains, Nasdaq has stayed in the spotlight as a crucial infrastructure...

If you are wondering whether ZIM Integrated Shipping Services is still a bargain or if the easy money has already been made, this article will walk through what the numbers are really saying about its value. The stock has been anything but quiet lately, with shares up 2.6% over the last week, 14.9% over the past month, and 36.3% over the last year, even though it remains down 17.5% year to date. These moves have been driven in part by shifting expectations around global freight rates and...

If you are wondering whether Patterson-UTI Energy is a bargain or a value trap at today’s price, you are not alone. This breakdown is designed to give you a clear, no-jargon answer. The stock has slipped 6.1% over the last week and is down 31.7% year to date, yet it is still up 25.6% over five years. This highlights how cyclical this name can be. Recent headlines have focused on shifting North American drilling activity and ongoing consolidation in oilfield services, both of which directly...

Wondering if A. O. Smith at around $68 a share is quietly undervalued or just fairly priced? You are not alone, and that is exactly what we are going to unpack here. Despite only a 1.0% return over the last year, the stock has climbed 6.9% in the past month after a softer 1.0% dip over the last week, hinting that sentiment may be shifting again. Recent headlines have focused on A. O. Smith expanding its water treatment and high efficiency water heating offerings, plus ongoing investment in...

Bank Midwest Partnership Puts Raymond James in Focus Raymond James Financial (RJF) just deepened its regional footprint through a new partnership with Bank Midwest, which is moving about $692 million in client assets and rebranding its wealth arm on Raymond James infrastructure. See our latest analysis for Raymond James Financial. That backdrop helps explain why investors have been comfortable paying around $163.01 today, with a modestly positive year to date share price return alongside a...

USA Rare Earth (USAR) has quietly turned heads after a choppy stretch, with the stock bouncing 2% in the latest session even as it remains down over the past 3 months. See our latest analysis for USA Rare Earth. With the share price now at $13.84, the stock’s 1 day share price return of 2.40% offers a small bounce against a still weak 90 day share price return of 14.83%. At the same time, the 1 year total shareholder return of 25.92% hints that longer term momentum is not entirely broken. If...

Bausch Health Companies (NYSE:BHC) just reported strong early participation in its exchange offer, with investors tendering roughly 2.7 billion dollars of existing 2028 secured notes into new 10.0% notes due 2032. See our latest analysis for Bausch Health Companies. This heavy early take up comes as the 1 month share price return of 13.72 percent has started to claw back some of this year’s weakness. The 1 year total shareholder return remains negative, but the 3 year total shareholder return...

Nuvalent (NUVL) just saw a fresh jolt of attention after veteran oncology executive Ron Squarer joined its board, a move that arrived as Wall Street sentiment toward the cancer focused biotech has turned more confident. See our latest analysis for Nuvalent. That backdrop of growing confidence is showing up in the numbers, with Nuvalent’s share price at $103.8 after a strong 90 day share price return of 35.39 percent and an impressive three year total shareholder return of 264.98 percent. This...

Earlier this month, UiPath highlighted that it is generating free cash flow, has completed an US$819.64 million buyback of 67,772,000 shares, and is actively pursuing tuck-in acquisitions after buying Peak, while also integrating its automation platform with Talkdesk to streamline complex customer-service workflows such as healthcare prior authorizations. These moves underscore UiPath’s effort to pair disciplined capital deployment with deeper AI-driven partnerships, using its agentic...

Earlier this week, shares of crypto-exposed companies rallied after bitcoin moved past US$90,000, lifting sentiment across miners and trading platforms, including CleanSpark. The surge followed Hut 8’s 15-year, very large Fluidstack AI infrastructure deal and Coinbase’s push into tokenized assets and onchain AI tools, underscoring how AI-linked demand is reshaping investor interest in digital-asset infrastructure. We’ll now examine how bitcoin’s renewed momentum and AI-driven...

If you are wondering whether NVIDIA is still worth buying after its massive run, you are not alone. This breakdown is designed to give you a clear, no nonsense view of the stock's value. Despite a blockbuster long term performance, with the share price up 1091.4% over 3 years and 1296.8% over 5 years, more recent moves have been mixed, up 3.4% over the last week but down 3.0% over the last month, while still sitting on a 30.9% gain year to date and 34.4% over the past year. Recent headlines...

Revolution Medicines (RVMD) just hit an important clinical milestone, randomizing the first patient in its RASolute 304 Phase 3 trial of daraxonrasib for post-surgery pancreatic cancer patients after chemotherapy. See our latest analysis for Revolution Medicines. The news lands as the stock trades around $78.78, with a powerful 90 day share price return of 80.94 percent and a three year total shareholder return of 257.44 percent, signaling strong, building momentum around Revolution Medicines...

Chewy (CHWY) just cleared a modest hurdle with third quarter earnings that edged past expectations. The story behind that beat matters more than the headline numbers for anyone watching the stock. See our latest analysis for Chewy. The latest guidance tweak, calling for around 8% adjusted full year net sales growth, comes as Chewy’s share price has slid, with a 90 day share price return of minus 15.67% and a five year total shareholder return of minus 68.79%. This suggests long term holders...

Earlier this month, Match Group said that CEO Spencer Rascoff will join its Board of Directors and Hinge founder Justin McLeod, now leading Overtone, will become Chairman while continuing to advise Hinge through March 2026. The move brings a founder with deep dating-app product experience and a focus on responsible, human-centered technology into Match Group’s boardroom leadership. Next, we’ll explore how Justin McLeod’s appointment as Chairman may reshape Match Group’s investment narrative...

Allstate (ALL) has quietly outperformed many peers this year, but the stock has slipped slightly over the past month, giving long term investors a fresh chance to reassess its insurance driven earnings power. See our latest analysis for Allstate. That modest pullback comes after a solid year to date, with a 6.8% year to date share price return and a 1 year total shareholder return of 8.0% suggesting steady, if not explosive, momentum as investors reassess insurance sector risks and earnings...

International Business Machines (IBM) keeps edging higher, with the stock up roughly 4% over the past month and nearly 13% in the past 3 months, inviting a closer look at what might be driving sentiment. See our latest analysis for International Business Machines. That recent strength is not happening in isolation. The latest share price of $300.98 sits on top of a solid year to date share price return of roughly 37 percent and a powerful multi year total shareholder return north of 200...